These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

987 related items for PubMed ID: 18550406

  • 21. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.
    Jernström H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):377-84. PubMed ID: 11319179
    [Abstract] [Full Text] [Related]

  • 22. The effect of economic status on height, insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in healthy Turkish children.
    Turan S, Bereket A, Furman A, Omar A, Berber M, Ozen A, Akbenlioglu C, Haklar G.
    Eur J Clin Nutr; 2007 Jun; 61(6):752-8. PubMed ID: 17164829
    [Abstract] [Full Text] [Related]

  • 23. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.
    Holmes MD, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):862-7. PubMed ID: 12223430
    [Abstract] [Full Text] [Related]

  • 24. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 25. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.
    Akanji AO, Suresh CG, Al-Radwan R, Fatania HR.
    Scand J Clin Lab Invest; 2007 Mar; 67(5):553-9. PubMed ID: 17763192
    [Abstract] [Full Text] [Related]

  • 26. Normal reference range of serum insulin-like growth factor (IGF)-I in healthy Thai adults.
    Plengpanich W, Mangkala J, Buranasukajorn P, Boonruang K, Sunthornyothin S, Suwanwalaikorn S, Khovidhunkit W, Sridama V, Snabboon T.
    J Med Assoc Thai; 2008 Nov; 91(11):1681-4. PubMed ID: 19127789
    [Abstract] [Full Text] [Related]

  • 27. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
    Ahmed RL, Thomas W, Schmitz KH.
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
    [Abstract] [Full Text] [Related]

  • 28. Body mass index, free insulin-like growth factor I, and physical function among older adults: results from the ilSIRENTE study.
    Onder G, Liperoti R, Russo A, Soldato M, Capoluongo E, Volpato S, Cesari M, Ameglio F, Bernabei R, Landi F.
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E829-34. PubMed ID: 16684849
    [Abstract] [Full Text] [Related]

  • 29. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
    Zhang P, Liu B, Li G, Wu L, Yu M, Ou Y, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):65-8. PubMed ID: 11953064
    [Abstract] [Full Text] [Related]

  • 30. [Reference values for IGF-I, IGFBP-1, IGFBP-3 and osteocalcin in healthy children in Zaragoza].
    Cortés Blanco A, Labarta Aizpún JI, Ferrández Longás A, Mayayo Dehesa E.
    An Esp Pediatr; 1999 Aug; 51(2):167-74. PubMed ID: 10495504
    [Abstract] [Full Text] [Related]

  • 31. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Panminerva Med; 1998 Jun; 40(2):103-6. PubMed ID: 9689829
    [Abstract] [Full Text] [Related]

  • 32. Characterization of the IGF system in 15 patients with Alström syndrome.
    Maffei P, Boschetti M, Marshall JD, Paisey RB, Beck S, Resmini E, Collin GB, Naggert JK, Milan G, Vettor R, Minuto F, Sicolo N, Barreca A.
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
    [Abstract] [Full Text] [Related]

  • 33. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J, Qureshi AR, Divino-Filho JC, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.
    Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
    [Abstract] [Full Text] [Related]

  • 34. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment.
    Zimmermann-Belsing T, Juul A, Juul Holst J, Feldt-Rasmussen U.
    Growth Horm IGF Res; 2004 Jun; 14(3):235-44. PubMed ID: 15125885
    [Abstract] [Full Text] [Related]

  • 35. Perturbed insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 are not associated with chronic widespread pain in men: results from the European Male Ageing Study.
    McBeth J, Tajar A, O'Neill TW, Macfarlane GJ, Pye SR, Bartfai G, Boonen S, Bouillon R, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Wu FC, EMAS Group.
    J Rheumatol; 2009 Nov; 36(11):2523-30. PubMed ID: 19833751
    [Abstract] [Full Text] [Related]

  • 36. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R, Ventura R, Palmi I, di Carlo S, Bacosi A, Bellver M, Olive R, Pascual JA, Pacifici R, Segura J, Zuccaro P, Pichini S.
    J Pharm Biomed Anal; 2008 Nov 04; 48(3):844-52. PubMed ID: 18617352
    [Abstract] [Full Text] [Related]

  • 37. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.
    Diabetes; 2006 Aug 04; 55(8):2333-9. PubMed ID: 16873698
    [Abstract] [Full Text] [Related]

  • 38. Gender differences in the insulin-like growth factor axis response to a glucose load.
    Flanagan DE, Holt RI, Owens PC, Cockington RJ, Moore VM, Robinson JS, Godsland IF, Phillips DI.
    Acta Physiol (Oxf); 2006 Jul 04; 187(3):371-8. PubMed ID: 16776662
    [Abstract] [Full Text] [Related]

  • 39. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
    Kehinde EO, Akanji AO, Mojiminiyi OA, Bashir AA, Daar AS, Varghese R.
    Prostate Cancer Prostatic Dis; 2005 Jul 04; 8(1):84-90. PubMed ID: 15775992
    [Abstract] [Full Text] [Related]

  • 40. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D, Potischman N, Dodd KW, Nicar M, McQuillan G, Lavigne JA, Barrett JC, Ballard-Barbash R.
    Cancer Epidemiol Biomarkers Prev; 2007 May 04; 16(5):1017-22. PubMed ID: 17507631
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.